Home/Pipeline/REASSOCIATED NATIVE KLH (RANKLH)

REASSOCIATED NATIVE KLH (RANKLH)

Advanced carrier protein/adjuvant for research and clinical use

Research / Pre-clinicalActive

Key Facts

Indication
Advanced carrier protein/adjuvant for research and clinical use
Phase
Research / Pre-clinical
Status
Active
Company

About BioSyn

BioSyn Corporation is a privately held biopharmaceutical company with a unique focus on hemocyanin and selenium-based therapeutics. Founded in 1980 and headquartered in Carlsbad, California, the company has established itself as the global leader in manufacturing high-purity KLH, a critical carrier protein and adjuvant used in over 100 clinical trials worldwide. Its vertically integrated operations include a dedicated GMP facility with specialized aquaria for the sustainable, non-lethal harvesting of Giant Keyhole Limpets. While generating revenue from research and clinical-grade product sales, BioSyn's pipeline includes its KLH products in various investigational uses and its Selenase® product for conditions like sepsis.

View full company profile